SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-293959
Filing Date
2023-12-13
Accepted
2023-12-13 08:31:30
Documents
13
Period of Report
2023-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d35885d8k.htm   iXBRL 8-K 39820
2 EX-99.1 d35885dex991.htm EX-99.1 22806
  Complete submission text file 0001193125-23-293959.txt   190319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcab-20231213.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20231213_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20231213_pre.xml EX-101.PRE 10813
7 EXTRACTED XBRL INSTANCE DOCUMENT d35885d8k_htm.xml XML 3219
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 231483043
SIC: 2836 Biological Products, (No Diagnostic Substances)